Name
The High Toll of High-Cost Conditions
Date & Time
Thursday, June 10, 2021, 10:20 AM - 10:44 AM
Description
People with cancer, cardiovascular disease and diabetes – historically high-cost conditions for employers – have been at high risk for complications for COVID-19. Can new treatments and approaches enable us to more effectively address these illnesses? How much will this cost employers?
Speakers
Thomas C. Squires, Esq. - Corning, Inc.
James Mansi - Moderna
Sarah Moseley, PhD - GRAIL Inc.
Mark Godwin, PharmD - UnitedHealthcare
Annette Powers, PharmD - Bristol Myers Squibb
James Mansi - Moderna
Sarah Moseley, PhD - GRAIL Inc.
Mark Godwin, PharmD - UnitedHealthcare
Annette Powers, PharmD - Bristol Myers Squibb
